Association between Mexican vaccination schemes and the duration of long COVID syndrome symptoms.

Publication date: Feb 12, 2025

The COVID-19 pandemic had a profound global impact, characterized by a high fatality rate and the emergence of enduring consequences known as Long COVID. Our study sought to gauge the prevalence of Long COVID syndrome in northeastern Mexico, correlating it with patients’ comorbidities and vaccination records. We carried out an observational cross-sectional approach, by administering a comprehensive questionnaire covering patients’ medical history, demographics, vaccination status, COVID-related symptoms, their duration, and any treatment received. Our participant cohort included 804 patients, averaging 41. 5 (SD 13. 6) years in age, with 59. 3% being women. Notably, 168 individuals (20. 9%) met Long COVID criteria. Our analysis of COVID-19 long lasting compared vaccination schemes, unveiling a significant difference between vaccinated and unvaccinated groups (pā€‰=ā€‰ā€‰

Open Access PDF

Concepts Keywords
Global Adult
Mexican Comorbidity
Northeastern COVID-19
Pandemic COVID-19 Vaccines
Vaccinated COVID-19 Vaccines
Cross-Sectional Studies
Female
Humans
Male
Mexico
Middle Aged
Post-Acute COVID-19 Syndrome
Prevalence
Risk Factors
SARS-CoV-2
Vaccination

Original Article

(Visited 1 times, 1 visits today)